For the quarter ending 2025-09-30, ALHC had $147,819K increase in cash & cash equivalents over the period. $139,059K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Payment-in-kind interest | - | - | - | 0 |
| Net income (loss) | 3,729 | 15,653 | -9,354 | -31,064 |
| Gain on sale of property and equipment | - | - | - | 9 |
| Provision for credit loss | 286 | 262 | - | 0 |
| Loss on extinguishment of debt | - | - | - | -3,020 |
| Loss on right of use assets | 0 | 0 | 0 | -8 |
| Gain on sale of property and equipment | 0 | 72 | - | -8 |
| Depreciation and amortization | 7,985 | 7,036 | 7,627 | 6,808 |
| Amortization-investment discount | 310 | 361 | 370 | 495 |
| Amortization-debt issuance costs | 440 | 441 | 440 | 315 |
| Amortization of payment-in-kind interest | - | - | - | -1,015 |
| Equity-based compensation | 16,227 | 15,553 | 17,187 | 16,236 |
| Non-cash lease expense | 932 | -149 | 395 | 404 |
| Accounts receivable | -62,808 | 69,104 | 60,155 | 15,052 |
| Prepaid expenses and other current assets | 27,993 | 12,533 | 43,800 | -16,696 |
| Other assets | -5 | 29 | 23 | 17 |
| Medical expenses payable | 73,642 | 58,420 | 106,946 | -7,337 |
| Accounts payable and accrued expenses | 2,626 | 3,346 | 5,208 | -4,295 |
| Deferred premium revenue | -72 | -80 | 273 | - |
| Accrued compensation | 5,264 | 10,662 | -7,577 | 5,819 |
| Lease liabilities | -1,013 | 85 | -65 | -33 |
| Net cash provided by operating activities | 144,556 | 29,130 | 16,616 | -8,711 |
| Purchase of investments | 10,193 | 17,096 | 17,905 | 6,676 |
| Sale of property and equipment | 0 | 75 | - | 0 |
| Maturities of investments | 18,005 | 17,295 | 22,695 | 10,040 |
| Sale of business | 0 | 1,065 | - | - |
| Purchase of business, net of cash received | - | - | - | 0 |
| Acquisition of property and equipment | 5,497 | 8,003 | 8,252 | 9,284 |
| Net cash (used in) provided by investing activities | 2,315 | -6,664 | -3,462 | -5,920 |
| Proceeds from long-term debt | 0 | 0 | - | 330,000 |
| Repurchase of noncontrolling interest | - | - | - | 0 |
| Payment of employment taxes related to release of restricted stock | 0 | 0 | 0 | 0 |
| Repayment of long-term debt | - | - | - | 215,000 |
| Debt issuance costs | 0 | 0 | 26 | 8,280 |
| Proceeds from stock option exercises | 948 | 1,616 | 207 | 155 |
| Contributions from noncontrolling interest holders | 0 | 0 | 0 | 0 |
| Net cash provided by financing activities | 948 | 1,616 | 181 | 106,875 |
| Net increase in cash | 147,819 | 24,082 | 13,335 | 92,244 |
| Cash and cash equivalents at beginning of period | 434,942 | - | - | - |
| Cash and cash equivalents at end of period | 620,178 | - | - | - |
Alignment Healthcare, Inc. (ALHC)
Alignment Healthcare, Inc. (ALHC)